7th NF-kB

International

Congress

Barcelona, October 7 to 9, 2026

Dear Friends and Colleagues,
After a very successful series of NF-kB European Workshops, we are now pleased to share with you a change in the logo of the meeting and the denomination, which from now on will be NF-kB International Congress, since it is expected to include researchers not only from Europe but also from worldwide. This time the meeting will include specific sessions dedicated to the most important processes where NF-kB subunits but also their principal regulators
play an essential role including stemness, cancer and development.

So, welcome to the 7th NF-kB International Congress that will be held in Barcelona from
October 7 to 9, 2026.

About the Venue

The Barcelona Biomedical Research Park (PRBB) is one of the largest biomedical research hubs in southern Europe. Located next to the sea in the Barceloneta district of Barcelona, the PRBB brings together a community of over 1,400 researchers, students, and support staff working across multiple disciplines in life sciences and biomedicine.

Inaugurated in 2006, the PRBB is more than just a building—it is a scientific ecosystem designed to foster collaboration, innovation, and excellence in research. It houses several leading research centers, including the Centre for Genomic Regulation (CRG), the Hospital del Mar Medical Research Institute (IMIM), the Barcelona Institute for Global Health (ISGlobal), the Department of Medicine and Life Sciences of Pompeu Fabra University (UPF), the Centre for Research in Environmental Epidemiology (CREAL), and the European Molecular Biology Laboratory – Barcelona site (EMBL Barcelona), among others.

Research at the PRBB spans a broad range of topics, from genetics and cell biology to public health, epidemiology, and computational biology. This multidisciplinary environment encourages synergy between basic and clinical research, aiming to translate scientific discoveries into tangible benefits for human health.

The park also emphasizes training, outreach, and ethical research practices. It hosts graduate and postgraduate programs in collaboration with UPF and other academic institutions, and it actively engages with the public through events, open days, and science communication initiatives.

As a model of co-location and interdisciplinary cooperation, the PRBB has positioned itself as a key player in the European research landscape. Its unique architecture, open science philosophy, and commitment to cutting-edge research make it a vibrant center for scientific advancement and innovation.

The Barcelona Biomedical Research Park (PRBB) is one of the largest biomedical research hubs in southern Europe. Located next to the sea in the Barceloneta district of Barcelona, the PRBB brings together a community of over 1,400 researchers, students, and support staff working across multiple disciplines in life sciences and biomedicine.

Inaugurated in 2006, the PRBB is more than just a building—it is a scientific ecosystem designed to foster collaboration, innovation, and excellence in research. It houses several leading research centers, including the Centre for Genomic Regulation (CRG), the Hospital del Mar Medical Research Institute (IMIM), the Barcelona Institute for Global Health (ISGlobal), the Department of Medicine and Life Sciences of Pompeu Fabra University (UPF), the Centre for Research in Environmental Epidemiology (CREAL), and the European Molecular Biology Laboratory – Barcelona site (EMBL Barcelona), among others.

Research at the PRBB spans a broad range of topics, from genetics and cell biology to public health, epidemiology, and computational biology. This multidisciplinary environment encourages synergy between basic and clinical research, aiming to translate scientific discoveries into tangible benefits for human health.

The park also emphasizes training, outreach, and ethical research practices. It hosts graduate and postgraduate programs in collaboration with UPF and other academic institutions, and it actively engages with the public through events, open days, and science communication initiatives.

As a model of co-location and interdisciplinary cooperation, the PRBB has positioned itself as a key player in the European research landscape. Its unique architecture, open science philosophy, and commitment to cutting-edge research make it a vibrant center for scientific advancement and innovation.

Program

The program is currently under development and is subject to change.
Wednesday, October 7th
 
8:45h
On-site registration and welcome coffee.
 
9:20h
OPENING KEYNOTE LECTURE (Pr. Ranjan Sen)
 
SESSION I: TRANSCRIPTIONAL REGULATION BY NF-KB
 
Chairs: Gourisankar Ghosh and Alex Hoffmann
 
10:00h
Structure-based biochemical analyses of NF-kappaB regulation by lkappaB and IKK – Tom Huxford
10:25h
Functional analaysis of NF-kB/RNA networks – Lienhard Schmitz
11:00h
Coffee Break
11:20h
The multifaceted role of NF-KappaB in hypoxia – Sonia Rocha
11:45h
Slot available
 
 
Short Talks session
 
 
12:10h
The role of NF-κB in stochastic immune responses – Dimitris Thanos
12:25h
Selected talk from Abstracts
12:40h
Selected talk from Abstracts
 
 
13:00h
LUNCH TIME AND POSTER VIEWING
 
 

SESION II: NF-KB IN INFLAMMATION AND IMMUNITY

Chairs:  Claus Scheidereit and Raquel Espín-Palazón

14:30h
Zooming in on NF-κB to understand inflammation and aging – Myong-Hee Sung
14:55h
IKK/NF-kB and cell death signalling in inflammation: lessons from mouse models – Manolis Pasparakis
15:30h
Coffee Break
15:50h
The signalling pathways that control the cellular decision to initiate inflammation – Ruaidhri Carmody
16:15h
New monogenic causes impacting the NFkB pathway in patients with autoimmunity and autoinflammation – Frederic Rieux-Laucat
16:40h
NF-kB and cell death in the aetiology of inflammatory diesase – Henning Walczak
17:10h
Slot available
Thursday, October 8th
SESSION III: NF-KB IN DEVELOPMENT AND CELL DIFFERENTIATION Chairs: Anna Bigas and Manolis Pasparakis
9:40h
In vivo NF-kB dynamics and their significance during development – Raquel Espin-Palazon
10:05h
Novel inborn errors of the human alternative NF-kB pathway and their consequences – Anne Puel
10:30h
Structural determinants of the non-canonical NFkB pathway – Emmanuel Dejardin
11:00h
Coffee Break
11:20h
Imbalances in the NFkB System disrupt lympho- and myelo-poiesis – Alex Hoffmann
11:45h
NFKB1 mutations in humans: genotype and phenotype – Bodo Grimbacher
12:10h
Slot available
12:50h
LUNCH TIME AND POSTER VIEWING
Short Talks session
14:20h
Selected talk from Abstracts
14:35h
Selected talk from Abstracts
SESSION IV: NF-KB-REGULATORY ELEMENTS Chairs: Tom Huxford and Dimitris Thanos
15:00h
Assembly and regulation of large p65 / RELA enhanceosomes – Michael Kracht
15:25h
Ubiquitin ligases cooperate in balancing NF-kB activation in T cells – Daniel Krappmann
15:50h
Ubiquitin Modulatory proteins in NF-kB signaling and disease – Rudi Beyaert
16:15h
IkBa as a master regulator of pluripotency – Anna Bigas
Short Talks session
16:40h
Selected talk from Abstracts
16:55h
Selected talk from Abstracts
17:10h
Selected talk from Abstracts
20:00h
CONGRESS DINNER (not included)
Friday, October 9th

SESSION V: NF-KB IN SOLID CANCERS LEUKEMIAS/LYMPHOMAS

Chairs: Veronique Baud and Leslie Stark

9:40h
RelB in metabolism and cancer –
Veronique Baud
10:05h
Mechanism of IKK2 activation and its implication on neurological diseases (and cancer) – Gourisankar Ghosh
10:30h
Loss of IkBa reshapes chromatin in Glioma –
Markus Bredel
11:00h
Coffee Break
11:20h
The central role of NF-kappaB in mediating leukemic T cell interactions with the microenvironment –
Nuno dos Santos
11:45h
NDP-heptose regulated NF-kB: infection, inflammation and cancer –
Michael Naumann

Short talks session

 
 
12:10h
Selected talk from Abstracts
12:25h
Selected talk from Abstracts
12:50h
LUNCH TIME AND POSTER VIEWING
 

SESSION VI: THERAPEUTIC TARGETING AND FUTURE DIRECTIONS

Chairs: Anne Puel and Myong-Hee Sung

14:20h
Computational Approaches to NF-κB: From Dynamic Signaling to Personalized Disease Models –
Jana Wolf
14:45h
Precision targeting of NF-kB in cancer with systems biology –
Simon Mitchell
15:10h
Cancer-selective targeting of the NF-kB pathway: from target discovery to human trials –
Guido Franzoso
15:35h
The development of SU1644 – a potent and selective IKKalpha inhibitor with applications in prostate and colorectal cancer –
Simon Mackay
 
 
16:05h
POSTER PRICES
16:20h
CLOSURE.
Past, present and future of the NF-kB congress

Neil Perkins

Scientific committee

Veronique Baud
Veronique Baud
University of Glasgow
Photographic Unit
Ruaidhri Carmody
Nuno dos Santos
Nuno Dos Santos
Raquel Espin Palazon
Raquel Espin-Palazon
Alex Hoffmann
Alex Hoffmann
www.matthiastunger.de
Daniel Krappmann
Neil Perkins
Neil Perkins
Sonia Rocha
Sonia Rocha
Lienhard Schmitz
Lienhard Schmitz

Speakers

Veronique Baud
Veronique Baud
Rudi Beyaert
Rudi Beyaert
Anna Bigas
Anna Bigas
Evoto
Markus Bredel
University of Glasgow
Photographic Unit
Ruaidhri Carmody
Emmanuel Dejardin
Emmanuel Dejardin
Nuno dos Santos
Nuno Dos Santos
Raquel Espin Palazon
Raquel Espin-Palazon
Lluis Espinosa
Lluís Espinosa
Guido Franzoso
Guido Franzoso
Bodo Grimbacher
Bobo Grimbacher
Alex Hoffmann
Alex Hoffmann
Tom Huxford
Tom Huxford
Prof. Dr. Michael Kracht, Rudolf-Buchheim-Institut für Pharmakologie der JLU (Professur für Pharmakologie und Toxikologie).

Foto: JLU / Rolf K. Wegst
Michael Kracht
www.matthiastunger.de
Daniel Krappmann
Michael Naumann
Michael Naumann
Manolis Pasparakis
Manolis Pasparakis
Neil Perkins
Neil Perkins
Anne Puel
Anne Puel
Frederic Rieux-Laucat
Frederic Rieux-Laucat
Sonia Rocha
Sonia Rocha
Lienhard Schmitz
Lienhard Schmitz
Myong-Hee Sung
Myong-Hee Sung
Henning Walczak
Henning Walczak
Jana Wolf
Jana Wolf

Contact

If you have any questions regarding registration, abstract submission, or general information about the NF-κB Congress 2026, please do not hesitate to contact us.

We are happy to assist you with any inquiries related to the scientific program, sponsorship opportunities, or logistical details of the event.

You can reach the Organizing Committee at:

contact@nfkbcongress.com

We will do our best to respond to your message as soon as possible.

Thank you for your interest in the NF-κB Congress, Barcelona 2026 — we look forward to welcoming you to our community of researchers!

Available soon

Our website is currently under construction, and some sections are still being updated. Please check back soon for the latest information about the program, speakers, registration, and more.
Thank you for your patience—we’re looking forward to seeing you at the event!